HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation.

Abstract
The objective of the study was to evaluate the frequency and clinical characteristics of ocular complications and their risk factors, as well as autologous serum tears (AST) for the treatment of dry eye in these patients. Data from the files of 124 patients who had undergone allogeneic haematopoietic progenitor cell transplantation (HPCT) were evaluated. In addition, 33 HPCT patients were examined and their data were compared with controls. Analysis of tears and AST was performed. Dry eye manifestation occurred in 32% of patients and was positively correlated with age over 27 years (P = 0.05), peripheral blood progenitor cell transplant (P = 0.002), chronic graft-versus-host disease (P = 0.0027), and chronic or acute myeloid leukaemia (P = 0.001). Dry mouth and Schirmer test < 5 mm were predictive factors for dry eye in HPCT patients (P = 0.002 and odds ratio 3.9 and P = 0.007, odds ratio = 5.9, respectively). Microbiological analysis revealed that six of 11 AST samples were contaminated after 30 days of use. The present study supports the role of potential risk factors for ocular complications and key elements to detect alterations in the tear film from HPCT patients. In addition, AST contamination must be considered after longer periods of use.
AuthorsS C Leite, R S de Castro, M Alves, D A Cunha, M E P Correa, L A da Silveira, A C Vigorito, C A de Souza, E M Rocha
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 38 Issue 3 Pg. 223-7 (Aug 2006) ISSN: 0268-3369 [Print] England
PMID16785864 (Publication Type: Journal Article)
Chemical References
  • Ophthalmic Solutions
Topics
  • Adolescent
  • Adult
  • Age Factors
  • Child
  • Dry Eye Syndromes (drug therapy, etiology)
  • Female
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Male
  • Middle Aged
  • Ophthalmic Solutions (chemistry, isolation & purification, therapeutic use)
  • Risk Factors
  • Serum

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: